EssilorLuxottica (EL) to transform Italian facilities into eyewear innovation hubs
EssilorLuxottica announced on 9 June 2026 its intention to commence connected eyewear production in Italy from early 2027, in partnership with Italian trade unions. This strategic initiative aims to transform the company's Italian facilities into innovation hubs for wearable technology, with an initial focus on the historic Agordo site. The company currently manufactures its Ray-Ban Meta smart glasses in Asia.
This development aligns with EssilorLuxottica's strategy to strengthen its local production capabilities and capitalise on Italian manufacturing expertise for wearable technology. The group already collaborates with Meta Platforms on the development of connected eyewear under the Ray-Ban and Oakley brands. The announcement had initially been met with a favourable market reaction, with the stock advancing 3.8% on 9 June to reach €179.70.
Today, 11 June 2026, EssilorLuxottica (EL) shares are trading at €177.55, a decline of 0.6% from their previous close of €178.60. This modest retreat follows a similar decline recorded yesterday, moderating the significant gains that had followed the initial announcement of this production relocation project.
Why initial enthusiasm for relocation is fading
EssilorLuxottica is a major player in global optics. The company designs, manufactures, and distributes a vast range of products, from high-tech corrective lenses to frames for iconic designer sunglasses, as well as smart glasses. Its customers include individuals seeking to correct their vision or protect their eyes, as well as opticians and retailers. The company generates its revenue by combining its expertise in visual health with the strong appeal of powerful fashion brands.
Today's stock market movement stems from a market re-evaluation of the initial enthusiasm generated by a major strategic announcement. On 9 June 2026, EssilorLuxottica revealed its intention to repatriate the production of smart glasses to Italy from early 2027, thereby transforming its local factories into innovation centres. This initiative, which shifts production currently based in Asia, had been welcomed by the markets, causing the share price to rise by 3.8% to €179.70. However, investors now seem to be factoring in the complexities and potential delays of such a transition, even if it aims to consolidate European production capabilities.
This digestion of information is reflected in the slight pullback observed; EssilorLuxottica's share is currently trading at €177.55, a decrease of 0.6% from its previous close of €178.60.
Imagine you announce to your friends that you are going to build a magnificent eco-friendly home. The initial enthusiasm is palpable, congratulations pour in. But a few days later, the conversation turns to building permits, material delivery times, and unforeseen costs. The excitement does not disappear, but it is tempered by an awareness of the practical realities of the project. This is somewhat what is happening here: the market is adjusting its glasses to see beyond the announcement and consider the execution.
EssilorLuxottica
EssilorLuxottica S.A. (EL) is a global leader in ophthalmic products, specialising in the design, manufacture, and distribution of lenses, frames, and sunglasses. Its operations span North America, Europe, Latin America, Asia, Oceania, and Africa, organised across five key segments: Wholesale, Retail, Lenses and Optical Instruments, Equipment, and Sunglasses and Readers. The company's diverse portfolio includes well-known lens brands such as Varilux, Crizal, and Transitions, alongside optical instruments for professionals. Its Equipment division supplies digital surfacing and lens coating machines. The Sunglasses and Readers segment offers a wide array of non-prescription eyewear under various brands, including Foster Grant and Bolon. With a network of 490 prescription laboratories and edging-mounting facilities, EssilorLuxottica was founded in 1849 and is headquartered in Paris, France.